Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer.
Rushworth LK, Loveridge C, Salji M, MacLeod M, Mui E, Sumpton D, Neilson M, Hedley A, Alexander L, McCartney E, Patel R, Wallace J, Delles C, Jones R, Leung HY.
Rushworth LK, et al. Among authors: leung hy.
BJU Int. 2023 Feb;131(2):236-243. doi: 10.1111/bju.15851. Epub 2022 Aug 12.
BJU Int. 2023.
PMID: 35844167
Free PMC article.
Clinical Trial.